Form 4: Mirum Pharmaceuticals CEO Christopher Peetz Sells Shares to Cover Tax Obligations

Mirum Pharmaceuticals CEO Christopher Peetz sold 9,102 shares of common stock on February 3, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On February 3, 2025, Christopher Peetz, the CEO of Mirum Pharmaceuticals, sold 9,102 shares of common stock.
• The sale was executed at a price of $48.2225 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Peetz directly owns 115,920 shares and indirectly owns 208,570 shares through The Peetz Family Trust.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes). It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future performance.

Stakeholder Impact

• The sale of shares by the CEO could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates